Suprathel® or Mepilex® Ag for treatment of partial thickness burns in children: A case control study

Aim: The study aim was to investigate if Suprathel (R) can be an adequate alternative to Mepilex (R) Ag for the treatment of partial-thickness scalds in children. Methods: A retrospective study including 58 children admitted to The Burn Centre in Linkoping, Sweden between year 2015 and 2022. Of the 58 children, 30 were dressed with Suprathel (R) and 28 with Mepilex (R) Ag. Outcomes investigated were healing time, burn wound infection (BWI), need for operations and number of dressing changes. Results: We found no significant differences in any of the outcomes. In the Suprathel (R) group 17 children and in the Mepilex (R) Ag group 15 children were healed within 14 days. Ten children from each group received antibiotics for suspected BWI and two from each group underwent an operation with skin grafting. Each group had on median four dressing changes. Conclusions: Two different treatments were compared for children with partial-thickness scalds, and the data indicates that similar results are received with both dressings.(c) 2023 Published by Elsevier Ltd.

Automated summary

This retrospective study compared the efficacy of two different dressings, Suprathel (R) and Mepilex (R) Ag, for the treatment of partial-thickness scalds in children. The results showed no significant differences in healing time, burn wound infection, need for operations, and number of dressing changes between the two groups.